SCHEMBL16769871

SCHEMBL16769871

Cc1ccc(S(=O)(=O)N2C/C(=C\c3ccc(F)cc3)C(=O)/C(=C/c3ccc(F)cc3)C2)cc1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ GPR183 P32249 1/20 0.52
▸ HSD11B1 P28845 2/20 0.50
▸ LMNA P02545 2/20 0.49
▸ THRB P10828 1/20 0.49
▸ ACHE P22303 3/20 0.48
▸ PAX8 Q06710 1/20 0.48
▸ MEN1 O00255 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ IKBKB O14920 1/20 0.48
▸ CYP1A2 P05177 1/20 0.48
▸ PKM P14618 2/20 0.45
▸ GAA P10253 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ MMP2 P08253 2/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ POLB P06746 1/20 0.44
▸ HTT P42858 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15562263 1.00 GPR183 (0.52) GPR183HSD11B1LMNATHRBACHE
SCHEMBL15562261 1.00 GPR183 (0.52) GPR183HSD11B1LMNATHRBACHE
SCHEMBL16755573 0.93 MEN1 (0.54) LMNAACHEMEN1KMT2ACYP1A2
SCHEMBL15561391 0.93 MEN1 (0.54) LMNAACHEMEN1KMT2ACYP1A2
SCHEMBL19840311 0.93 MEN1 (0.54) LMNAACHEMEN1KMT2ACYP1A2
SCHEMBL31238043 0.88 LMNA (0.45) GPR183HSD11B1LMNATHRBACHE
SCHEMBL16755523 0.86 DRD3 (0.50) GPR183ACHEMEN1KMT2ACYP1A2
SCHEMBL19840309 0.86 ACHE (0.48) LMNAACHEPAX8MEN1KMT2A
SCHEMBL19840310 0.86 DRD3 (0.50) GPR183ACHEMEN1KMT2ACYP1A2
SCHEMBL16755569 0.86 ACHE (0.48) LMNAACHEPAX8MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9884825-B2 Curcumin analogs and methods of making and using thereof GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2018-02-06 — — US disclosed
US-9884825-B2 Curcumin analogs and methods of making and using thereof GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2018-02-06 — — US disclosed
US-20150152056-A1 Curcumin Analogs and Methods of Making and Using Thereof UNIVERSITY OF DELHI (IN) 2015-06-04 — — US disclosed
US-20150152056-A1 Curcumin Analogs and Methods of Making and Using Thereof UNIVERSITY OF DELHI (IN) 2015-06-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150152056-A1 Curcumin Analogs and Methods of Making and Using Thereof COX15, HCCS, HMOX2 GPR183 3597/4885HSD11B1 766/4885LMNA 515/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback